Prednisone for Sciatica: Prescribing Guidance
Based on the highest-quality evidence, prescribe prednisone 60 mg daily for 5 days, then 40 mg daily for 5 days, then 20 mg daily for 5 days (total 15-day tapering course, cumulative dose 600 mg) for acute severe sciatica refractory to NSAIDs and physical therapy. 1
Evidence Supporting This Regimen
The most rigorous trial evaluating oral steroids for sciatica—a randomized, double-blind, placebo-controlled study of 269 patients—demonstrated that this specific 15-day tapering protocol produces:
- Modest functional improvement: 6.4-point greater improvement in Oswestry Disability Index at 3 weeks (P=0.006) and 7.4-point greater improvement at 52 weeks (P=0.005) compared to placebo 1
- No significant pain reduction: Only 0.3-point difference at 3 weeks (P=0.34) and 0.6-point difference at 52 weeks (P=0.15) on a 0-10 pain scale 1
- Quality of life benefit: 3.3-point greater improvement in SF-36 Physical Component Summary at 3 weeks (P=0.001) 1
Critical Prescribing Details
Dosing Schedule
- Days 1-5: Prednisone 60 mg once daily 1
- Days 6-10: Prednisone 40 mg once daily 1
- Days 11-15: Prednisone 20 mg once daily 1
- Total cumulative dose: 600 mg 1
Timing and Administration
- Administer in the morning prior to 9 AM to minimize HPA axis suppression 2
- Take with food or milk to reduce gastric irritation 2
- Consider prescribing a proton pump inhibitor for GI prophylaxis, particularly given the patient's prior NSAID use 3
Setting Realistic Patient Expectations
You must counsel the patient that prednisone provides only modest functional improvement and does NOT significantly reduce leg pain. 1 The primary benefit is improved disability scores and physical function, not pain relief. 1
The clinical course of sciatica is generally favorable regardless of treatment, with most patients improving over 6-8 weeks. 4 This natural history makes it difficult to attribute improvement solely to medication.
Adverse Effects to Monitor
The prednisone group experienced significantly higher rates of adverse events compared to placebo (49.2% vs 23.9%, P<0.001). 1 Common short-term effects include:
- Insomnia and mood changes 1
- Increased appetite and weight gain 1
- Hyperglycemia (monitor in patients with diabetes risk factors) 2
- Gastrointestinal symptoms 1
Important Clinical Caveats
When NOT to Use This Regimen
- Non-radicular back pain: Systemic corticosteroids show no benefit over placebo for acute non-radicular low back pain and should NOT be used 5
- Muscle spasm without radiculopathy: Corticosteroids are ineffective; use NSAIDs plus skeletal muscle relaxants instead 5
Alternative Evidence
One smaller trial (n=59) using prednisolone 50 mg daily for 5 days tapered over 10 days showed greater pain reduction in cervical radiculopathy (75.8% vs 30% improvement, P<0.001). 6 However, this studied cervical rather than lumbar radiculopathy and used a different dosing regimen. 6
Epidural Injections Are Not Superior
Epidural methylprednisolone injections offer no significant functional benefit over placebo at 3 months and do not reduce surgery rates (25.8% vs 24.8%, P=0.90). 7 The oral route is therefore preferred for its convenience and similar efficacy profile. 1
Contraindications to Verify Before Prescribing
As specified in your clinical scenario, ensure absence of:
- Uncontrolled diabetes (prednisone will worsen glycemic control) 2
- Active infection (immunosuppression risk) 2
- Peptic ulcer disease (increased GI bleeding risk) 2
- Severe osteoporosis (accelerated bone loss) 2
- Psychosis (corticosteroids can precipitate psychiatric symptoms) 2
- Hypersensitivity to prednisone 2
Follow-Up Strategy
- Reassess at 3 weeks to evaluate functional improvement using validated disability measures 1
- Do NOT abruptly discontinue after the 15-day course; the taper is built into the regimen 2
- If no improvement by 3 weeks, consider MRI if not already obtained and neurosurgical consultation for possible discectomy 1
- Surgery discussion: Discectomy is effective for short-term relief but shows no long-term advantage over conservative care, so shared decision-making is essential 4
Why NSAIDs Alone Are Insufficient in This Case
Your patient has already failed NSAIDs, which show only modest benefit for sciatica (mean difference -4.56 on 0-100 VAS, not statistically significant). 8 The evidence for NSAIDs in sciatica is very low quality with high heterogeneity. 8 Adding prednisone provides an additional mechanism targeting nerve root inflammation beyond what NSAIDs achieve. 1